At present, the state continues to increase policy support for medical devices, and policies are intensive. As early as January 9th at the National Science and Technology Work Conference, Minister of Science and Technology Wan Gang said that in 2018, the Ministry of Science and Technology will accelerate the localization, high-end, branding and internationalization of medical devices. On January 30, the State Food and Drug Administration and the Ministry of Science and Technology jointly issued the "Guiding Opinions on Strengthening and Promoting the Innovation of Food and Drug Science and Technology", clearly targeting the development of medical device technology, building an innovation base, and establishing a synergy mechanism for production, education and research for system deployment. It can be seen that domestic medical equipment has ushered in unprecedented new development opportunities. Recently, a seminar on China's tumor micro-invasive technology R&D and application, sponsored by Health Times and supported by Shanghai Yisi Medical Technology Co., Ltd., was held in Beijing. Fan Xiaodong, vice president of China Medical Device Industry Association, Meng Xianli, editor-in-chief of Health Times, Zhao Ping, chairman of China Cancer Foundation, and many famous cancer surgeons from the top three hospitals attended the seminar to discuss the technological innovation model in China's micro-invasive field. According to Fan Xiaodong, vice president of China Medical Device Industry Association, the State Intellectual Property Office issued a clear list of the top ten industries supported by the state in 2018. Among the high-end medical devices in the health industry, a total of six categories of medical devices will be supported. . From this point of view, in the critical period of national economic transformation, the medical device industry as a key area of the real economy will receive key support. Experts attending the meeting also said that the domestic medical device industry has entered a second period of rapid development. Under the guidance of policy support and technology, high-end domestic medical device import substitution will press the shortcut key, and the cost-effective Chinese manufacturing will launch a stronger challenge to the international big brands on a global scale. Especially with the advent of the era of precision medicine, cancer treatment has become more minimally invasive, efficient and individualized, and has gradually become the mainstream of cancer treatment. Minimally invasive treatment from the past single blood vessel embolization treatment of liver cancer to the current interventional embolization for lung cancer, ovarian cancer, kidney cancer, etc., from ultrasound-guided percutaneous puncture to CT, MRI-guided puncture diagnosis and puncture treatment of whole body tissues and organs, micro Invasive treatment has been deeply involved in the treatment of whole body tissues and organs, various tumors, and organic combination with surgery, radiotherapy, chemotherapy, etc., which not only reflects individualization but also reflects the comprehensive advantages. This is the progress of science and technology, and it is the gospel of cancer patients. More and more cancer patients benefit from it and bring development benefits to the development of minimally invasive devices. In this regard, experts believe that clinicians should also be involved in the design of surgical instruments. In the history of surgical development in the past century, many foreign experts have directly participated in the innovation of surgical instruments. In the past 20 years, the country has also realized the necessity of involving clinicians in the creation of devices. In particular, minimally invasive surgery has been in the history of twenty or thirty years, and many traditional surgical instruments should be innovated within the framework of minimally invasive surgery. But this innovation must not be limited to clinical, but the outbreak of multidisciplinary synergy. Some innovative wisdom that has been sublimated in the clinical field, medical device companies as a bridge, and then through the material, machinery, electronics, software, or interdisciplinary combination in the field of sound and optoelectronics, and ultimately produce a complete technical solution, will emerge high-end Innovations in the field of medical devices. Optimize the allocation of resources for scientific and technological innovation, adopt a combination of production, study and research, and technology innovation alliances. In accordance with the principle of building and sharing, select the dominant units in talents, disciplines and resources, and focus on the strategic needs of health China construction and medical system reform. Cultivating a number of innovative medical device innovation platforms is the key to the future development of domestic cancer innovation technology. It is understood that in the "Guiding Opinions on Strengthening and Promoting the Innovation of Food and Drug Science and Technology", the importance of innovation ability in the development of medical equipment has been clarified again. It is required to optimize the layout of scientific and technological innovation, build a high-level scientific and technological innovation base, create a research and innovation atmosphere, and implement special financial support for innovative medical devices. Under the new situation of continuous innovation, intelligent integration and technology promotion, domestic medical device entrepreneurs can clarify the development of the industry and focus on innovation. At the same time, intellectual property protection issues were frequently raised in this seminar. Among them, there are many governments that attach great importance to supporting independent innovation and intellectual property internationalization policies, and with the rapid development of science and technology, the process of continuous integration and innovation in the field of medical devices, on the one hand, there is a large number of simple reproductions of imitation infringement in the industry. Phenomenon, on the other hand, needs to face global competition and disputes. It is undeniable that domestic medical device enterprises must go global and move toward high-end development. They must not only focus on R&D and technological innovation, but also need to improve the level of intellectual property declaration and protection, and actively carry out the globalization of intellectual property. Nie Honglin, founder and chief scientist of Shanghai Yisi Medical Technology Co., Ltd., said that Yisi Medical has tried to incorporate innovative clinical surgeons, scientists from relevant research institutes, and engineering experts into the R&D team to fully understand the experts. In the clinical first-line demand for medical equipment, summed up the innovative ideas and directions. Moreover, unlike the international medical giants who have collected the valuable innovation wisdom of medical experts, the only way to pay for a cheap technical consulting fee is that Yisi Medical has jointly filed patents with experts after successful product development, and clinicians The first place of all inventors. After the company has the corresponding economic benefits, let the experts participate in the distribution of profits. It is reported that through the cooperation of this kind of think tank model, Yisi Medical has launched a large number of technological innovations, actively applied for invention patents, and implemented the global intellectual property strategic layout, and has achieved stage results. At present, Yisi Medical has applied for 87 patents and applied for 42 trademarks.